Observational Study on the Diagnostic Evaluation of the Intestinal Microbiota of Patients With COVID-19.

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

143 participants

Study Classification

OBSERVATIONAL

Study Start Date

2020-04-28

Study Completion Date

2021-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

In the context of the COVID-19 pandemic, the role of the gut microbiome is yet unknown. The aim of this trial is to evaluate the clinical contribution of the gut microbiome composition and diversity on the disease severity and to estimate the viral load in stool samples.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Intestinal Microbiota of Patients Hospitalized With Sars-CoV-2

NCT05178238

COVID-19

ACTIVE_NOT_RECRUITING

Le French Gut: Characterization of Gut Microbiota Profiles in France

NCT05758961

General Population

RECRUITING

SARS-CoV-2 in Stools Compared to Respiratory Viral Strains.

NCT05567419

SARS-CoV-2 Infection

UNKNOWN

A Study to Explore the Role of Gut Flora in COVID-19 Infection

NCT04359836

Gut Microbiome Gastrointestinal Microbiome COVID +7 more

RECRUITING

Characterization of Fecal Microbiota in a Population Aged 50 to 75 Years Targeted by Seasonal Vaccination

NCT05972590

Elderly Volunteers

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

COVID-19

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

COVID-19 patients

Hospitalised COVID-19 patients

1test1

Intervention Type DIAGNOSTIC_TEST

Loss of bacterial diversity diagnosis

Controls

Exposed medical staff

1test1

Intervention Type DIAGNOSTIC_TEST

Loss of bacterial diversity diagnosis

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

1test1

Loss of bacterial diversity diagnosis

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* COVID-19 positive patients: hospitalised patients diagnosed with COVID-19 in one of the investigating sites, and able to provide a stool sample.
* Control subjects: Medical and paramedical personnel working at one of the investigating sites, having been in direct contact with the patients.
* Aged between 18 and 95 years.
* Subjects able to read the French-language study information leaflet.
* Patients with social cover.

Exclusion Criteria

* COVID-19 negative patients.
* Patients in critical care, heart failure or respiratory failure.
* Unable to provide naturally a stool sample.
* Patients without social cover.
* Pregnant women

Minimum Eligible Age

18 Years

Maximum Eligible Age

95 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No